Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MS-CTA of pulmonary arteries and MS-CTP of lower extremity veins with Iomeron (iomeprol)
2004-001210-13Phase 4Completed
- Sponsor
- Bracco Imaging
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of iomeprol in pulmonary embolism (PE) and deep vein thrombosis (DVT) (2 arms), sponsored by Bracco Imaging. Primary endpoint: Pulmonary artery attenuation values with Iomeron 300 mgI/mL vs 400 mgI/mL. Started Oct 2004; status: completed.
02
Drugs
iomeprol
03
Conditions
pulmonary embolism (PE)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2004-001210-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001210-13.